A. De Fermin Cortes

A. De Fermin Cortes

Auto-generated profile, based on publicly available information

A. De Fermin Cortes

Pacific Lutheran University, Seattle, United States

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2025 in Physiotherapy Quarterly
Verified
Journal Article
Open access
HOHernán Andrés de la Barra Ortiz
Hernán Andrés de la Barra Ortiz
ACAntonia Cortés
Antonia Cortés
FPFernando Pizarro
Fernando Pizarro
NSNicolás Sabaj
Nicolás Sabaj
ESEsteban Sainz
Esteban Sainz
Introduction: High-intensity laser therapy (HILT) is a recent resource promoted as an alternative to relieve pain and improve function in patients with subacromial impingement syndrome (SAIS). The aim of this review was to assess the effects of HILT on pain in patients with SAIS.Methods: Electronic databases, including PubMed, Web of Science, Scopus, CINAHL, Science Direct, Cochrane Library, the PEDro database, and Google Scholar (updated to January 8, 2025), were searched for clinical trials comparing HILT with other physical therapy treatments in patients with SAIS. The main outcomes evaluated were pain intensity, range of motion (ROM), and disability for different scales and instruments. The results of VAS, range of motion, CMS, and SPADI were analysed, evaluating the quality of RCTs with the Cochrane risk of bias (RoB) 2.0 tool and the evidence with the GRADE approach.Results: Nineteen studies were included, generally presenting a low RoB, except for outcome data measurement and bias due to deviations from the intended intervention. RCTs reported a reduction in pain and an improvement in functionality in the meta-analysis. VAS MD = –1.56 cm (95% CI: –2.1,1.0); CMS MD = 4.0% (95% CI: 1.7, 6.2). Furthermore, there were significant improvements in flexion and abduction favouring HILT: flexion MD = 12.8° (95% CI: 2.5, 23.1);abduction MD = 15.3° (95% CI: 4.4,26.1). Only changes in pain and ROM were both statistically significant (p < 0.05) and clinically significant.Conclusions: This SR supports the effects of HILT on pain, ROM, and disability. It agrees with previous reviews on LLLT, validating both treatment options. Although the evidence was assessed as important, methodological inconsistencies are noted in some RCTs that could affect the certainty.

18 October 2023 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
MRM. Rosenfeld
M. Rosenfeld
COC. O’rOurke
C. O’rOurke
PVP. Vu
P. Vu
ACA. De Fermin Cortes
A. De Fermin Cortes
AKA. Kelly
A. Kelly
SHS. Heltshe
S. Heltshe

9 June 2023 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
MRM. Rosenfeld
M. Rosenfeld
APA. Paynter
A. Paynter
PVP. Vu
P. Vu
ACA. de Fermin Cortes
A. de Fermin Cortes
AKA. Kelly
A. Kelly
SHS. Heltshe
S. Heltshe